Skip to search.
 BSE Up0.19% NSE Up0.28%

More On AARTIDR.BO

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Aarti Drugs Ltd. (AARTIDR.BO)

-BSE

210.15 Up 19.10(10.00%) 17 May 2:14PM

Add to Portfolio
ProfileGet Profile for:
Aarti Drugs Ltd.
74 Matru Smruti Road No 4
Scheme 6 Sion E
Mumbai, 400022
India - Map
Phone: 91 22 2407 2249
Fax: 91 22 2407 3462
Website: http://www.aartidrugs.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Aarti Drugs Limited engages in the manufacture and sale of bulk drugs and its intermediates in India and internationally. It offers various active pharmaceutical ingredients in the therapeutic categories, such as anti inflammatory, cardioprotectant, antidiarrhoeals/antiprotozoals, antifungals, antiarthritis/osteoporosis, antihistamine, antibiotic, antidiabetic, alzheimer’s treatment, antihypertensive, antiBPH, sedative, traquilizar, antipsychotic, and vitamins. The company also provides pharmaceutical ingredients that primarily include 2 methyl 5 nitro imidazoles, 2 methyl imidazoles, imidazoles, 1 butyl imidazoles, 2 ethyl imidazoles, 2,6 dichloro phenylamines, diclofenac free acids, 1-2,6, Dichlorophenyl C2-2 Indolinones, 1 methyl amine 1 methyl thio C2 nitro ethane, methyl nicotinates/ethyl nicotinates/benzyl nicotinates, 2 phenoxy anilines, 2 phenoxy methane sulphamides, 4 sulphonamidophenylhydrazine hydrochlorides, tartrate of methyl alpha amino acetates, and methyl alpha C acetate hydrochloride salts; and various other ingredients for irbesartan, zolpidem tartrate, tamsulosin HCL, raloxifene, leflunomide, and levocetirizine. In addition, Aarti Drugs offers steroids comprising hydrocortisone sodium succinate sterile, hydrocortisone acetate, and hydrocortisone hemisuccinate, as well as various specialty chemicals. The company was founded in 1984 and is based in Mumbai, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Aarti Drugs Ltd.

Key Executives 
 PayExercised
Mr. Harshit M. Savla , 51
Joint Managing Director, Exec. Director and Member of Shareholders' Grievance Committee
10.53MN/A
Mr. Prakash M. Patil , 66
Managing Director, Chief Exec. Officer, Exec. Director, Member of Audit Committee and Member of Remuneration Committee
11.13MN/A
Mr. Harit P. Shah , 50
Whole-Time Director and Member of Shareholders' Grievance Committee
10.23MN/A
Mr. Uday M. Patil , 50
Whole-Time Director
443.00kN/A
Shri Adhish P. Patil , 30
Chief Financial Officer
N/AN/A
Amounts are as of 31-Dec-2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.